These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 29651119)

  • 21. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
    Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
    Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies.
    McLeish E; Slater N; Mastaglia FL; Needham M; Coudert JD
    Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38243695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and classification of idiopathic inflammatory myopathies.
    Lundberg IE; Miller FW; Tjärnlund A; Bottai M
    J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):1. PubMed ID: 19336018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spectrum of idiopathic inflammatory myopathies in South Africa.
    Chinniah KJ; Mody GM
    Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory muscle disease - An update.
    Baig S; Paik JJ
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-Reported Outcomes in Adult Idiopathic Inflammatory Myopathies.
    DiRenzo D; Bingham CO; Mecoli CA
    Curr Rheumatol Rep; 2019 Nov; 21(11):62. PubMed ID: 31741079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.
    Rider LG; Yip AL; Horkayne-Szakaly I; Volochayev R; Shrader JA; Turner ML; Kong HH; Jain MS; Jansen AV; Oddis CV; Fleisher TA; Miller FW
    Clin Exp Rheumatol; 2014; 32(5):689-96. PubMed ID: 25068290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis.
    Rosina S; Consolaro A; van Dijkhuizen P; Pistorio A; Varnier GC; Bovis F; Nistala K; Maillard S; Civino A; Tsitsami E; de Inocencio J; Jelusic M; Vojinovic J; Espada G; Makay B; Katsicas MM; Pratsidou-Gertsi P; Lazarevic D; Rao AP; Pires Marafon D; Martini A; Pilkington C; Ruperto N; Ravelli A
    Rheumatology (Oxford); 2019 Jul; 58(7):1196-1205. PubMed ID: 30690571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of new biomarkers of idiopathic inflammatory myopathy.
    Lu X; Peng Q; Wang G
    Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comprehensive understanding and study on idiopathic inflammatory myopathies to improve its diagnosis and treatment].
    Xie QB; Liu G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):792-6. PubMed ID: 24325114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):2. PubMed ID: 19336019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ; Amato AA
    Neurol Clin; 2014 Aug; 32(3):595-628, vii. PubMed ID: 25037081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of exercise in the rehabilitation of idiopathic inflammatory myopathies.
    Alexanderson H; Lundberg IE
    Curr Opin Rheumatol; 2005 Mar; 17(2):164-71. PubMed ID: 15711230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
    Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
    Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic inflammatory myopathies.
    van der Kooi AJ; de Visser M
    Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
    Isenberg DA; Allen E; Farewell V; Ehrenstein MR; Hanna MG; Lundberg IE; Oddis C; Pilkington C; Plotz P; Scott D; Vencovsky J; Cooper R; Rider L; Miller F;
    Rheumatology (Oxford); 2004 Jan; 43(1):49-54. PubMed ID: 12867580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.
    Lundberg IE; Tjärnlund A; Bottai M; Werth VP; Pilkington C; Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Dankó K; Dimachkie MM; Feldman BM; Torre IG; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song YW; Vencovsky J; Ytterberg SR; Miller FW; Rider LG;
    Ann Rheum Dis; 2017 Dec; 76(12):1955-1964. PubMed ID: 29079590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.
    Saygin D; DiRenzo D; Raaphorst J; de Groot I; Bingham CO; Lundberg IE; Regardt M; Sarver C; de Visser M; Maxwell LJ; Beaton D; Kim JY; Needham M; Alexanderson H; Christopher-Stine L; Mecoli CA; Park JK;
    Semin Arthritis Rheum; 2024 Feb; 64():152339. PubMed ID: 38141522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.